Multi-Leu peptide
Selected Variant
HY-P10422
Size: 1 Each
Multi-Leu peptide (ML-peptide) is a potent inhibitor of PACE4 (Ki=22 nM) . Multi-Leu peptide can competitively bind to the active site of PACE4 by simulating the substrate sequence of PACE4, thereby inhibiting its catalytic activity. Multi-Leu peptide can be used to study the specific mechanism of PACE4 in the development of prostate cancer[1].
Product Specifications
CAS Number
1413058-07-7
Product Name Alternative
ML-peptide, Multi-Leucine (ML) -peptide
UNSPSC
12352209
Target
Autophagy
Type
Peptides
Related Pathways
Autophagy
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/multi-leu-peptide.html
Smiles
O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N)=O)=O)=O)=O)=O)=O)=O)=O)C
Molecular Formula
C49H94N16O9
Molecular Weight
1051.37
References & Citations
[1]Łepek T, et al. Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations[J]. European journal of cell biology, 2017, 96 (5) : 476-485.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog